Skip to main content
. 2020 May 6;9(13):4622–4631. doi: 10.1002/cam4.3113

Figure 2.

Figure 2

Assessment of the QUANTEC, Appelt, and Thor models in predicting ≥ grade 2 radiation pneumonitis (RP2) in patients treated with concurrent chemoradiation alone cohort (cCRT, grey quintiles) and patients treated with concurrent chemoradiation and consolidative durvalumab (cCRT + durvalumab, orange quintiles). Note: Black dotted identity lines have been inserted to reflect over/underestimation of RP2 prediction by each model